Department of Labor Seal photos representing the workforce - digital imagery© copyright 2001 photodisc, inc.
Department of Labor Seal www.osha.gov   [skip navigational links] Search    Advanced Search | A-Z Index
Vanadium Fume (as V<SUB>2</SUB>O<SUB>5</SUB>) Chemical Sampling Information
Vanadium Fume (as V2O5)

General Description
    Synonyms: Vanadium pentoxide fume; Divanadium pentoxide fume; Vanadic anhydride fume; Vanadium oxide fume; Other synonyms vary depending upon the specific vanadium compound.

    OSHA IMIS Code Number: 2571

    Chemical Abstracts Service (CAS) Registry Number: 1314-62-1

    NIOSH, Registry of Toxic Effects (RTECS) Identification Number: YW2460000

    Department of Transportation Regulation Number (49 CFR 172.101) and Guide: 2862 151

    NIOSH Pocket Guide to Chemical Hazards, Vanadium fume: chemical description, physical properties, potentially hazardous incompatibilities, and more
Exposure Limits
    OSHA Permissible Exposure Limit (PEL) for General Industry: 29 CFR 1910.1000 Z-1 Table -- 0.1 mg/m3 Ceiling

    OSHA Permissible Exposure Limit (PEL) for Construction Industry: 29 CFR 1926.55 Appendix A -- 0.1 mg/m3 Ceiling

    OSHA Permissible Exposure Limit (PEL) for Maritime: 29 CFR 1915.1000 Table Z-Shipyards -- 0.1 mg/m3 Ceiling

    American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value (TLV): 0.05 mg/m3 TWA - Respirable fraction; see Appendix C paragraph C.; Appendix A4 - Not Classifiable as a Human Carcinogen; BEI (TLV listed under Vanadium pentoxide)

    National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Limit (REL): 0.05 mg V/m3 Ceiling (15 Minutes)
Health Factors
    NIOSH Immediately Dangerous To Life or Health Concentration (IDLH): 35 mg V/m3

    Potential symptoms: Irritation of eyes, throat; green tongue, metallic taste, sore throat; cough, fine rales, wheezing, bronchitis, dyspnea (breathing difficulty), pulmonary edema; epistaxis (bloody nose); eczema; conjunctivitis; headache, dry mouth, dizziness, nervousness, insomnia, tremor; INGES ACUTE: Abdominal cramps, nausea, vomiting, diarrhea (with black stools); drowsiness, unconsciousness.

    Health Effects: Irritation – Eye, Nose, Throat, Skin---Marked (HE14) Acute and chronic bronchial damage (HE11 and HE10).

    Affected organs: Eyes, skin, respiratory system

    Notes:
    1. EPA’s oral reference dose (daily oral exposure likely to be without an appreciable risk of deleterious effects during a lifetime) of vanadium pentoxide is 0.009 mg/kg/day.
    2. Two-year inhalational studies by the NTP found that vanadium pentoxide was a lung carcinogen in male rats and male and female mice.
    3. Since vanadium is mainly excreted by the kidneys, with a terminal half-life in serum of about 10 days, urinary vanadium is used as a biomarker of occupational exposure to vanadium pentoxide.
    4. The ACGIH established a biological threshold concentration in urine collected at the end of the work week of 50 µg of vanadium/gram of creatinine in urine. The concentration in the general population is usually less than 1 µg V/gram creatinine.

    Date Last Revised: 02/14/2006

    Literature Basis:
    • NIOSH Pocket Guide to Chemical Hazards: Vanadium fume.
    • International Chemical Safety Cards (WHO/IPCS/ILO): Vanadium pentoxide.
    • U.S. EPA Integrated Risk Information System: Vanadium pentoxide (CASRN 1314-62-1).
    • Barceloux, D.G.: Vanadium. J. Toxicol. Clin. Toxicol. 37(2): 265-278, 1999.
    • Heinemann, G., Fichtl, B. and Vogt, W.: Pharmacokinetics of vanadium in humans after intravenous administration of a vanadium containing albumin solution. Br. J. Clin. Pharmacol. 55(3): 241-245, 2003.
    • Irsigler, G.E., Visser, P.J. and Spangenberg, P.A.L.: Asthma and chemical bronchitis in vanadium plant workers. Am. J. Ind. Med. 35(4): 366-374, 1999.
    • Pohanish, R.P. (editor): Vanadium Pentoxide. In, Sittig’s Handbook of Toxic and Hazardous Chemicals and Carcinogens, Fourth Ed., Vol. 2. Norwich, NY: Noyes Publications, William Andrew Publishing, 2002, pp. 2310-2312.
    • Ress, N.B., et al.: Carcinogenicity of inhaled vanadium pentoxide in F344/N rats and B6C3F1 mice. Toxicol. Sci. 74(2): 287-296, 2003.
Monitoring Methods used by OSHA
    Laboratory Sampling/Analytical Method:

    • sampling media: Mixed Cellulose Ester Filter (MCEF) 0.8 microns
      maximum volume: 960 Liters   minimum volume: 480 Liters   maximum flow rate: 2.0 L/min (TWA)
      maximum volume: 30 Liters   maximum flow rate: 2.0 L/min (Ceiling)
      current analytical method: Inductively Coupled Argon Plasma; ICP/DCP-AES
      method reference: OSHA Analytical Method (OSHA ID-125G)
      method classification: Fully Validated
      note: Analytical method does not distinguish between dust and fume. If confirmation of Vanadium Pentoxide is necessary use the following sampling procedure:

    • sampling media: Tared Low Ash Polyvinyl Chloride (LAPVC) filter 5 microns
      maximum volume: 960 Liters   minimum volume: 480 Liters   maximum flow rate: 2.0 L/min
      current analytical method: X-ray Diffraction, XRD; and X-ray Fluorescence, XRF
      method reference: OSHA Analytical Method (OSHA ID-185)
      method classification: Fully Validated
      note: Submit as a separate sample.
* All Trademarks are the property of their respective owners.

 Safety and Health
 Topics
 
  Chemical Sampling Information:
  Vanadium Fume (as V2O5)
  General Description
  Exposure Limits
  Health Factors
  Monitoring
     
 
 
Page last updated: 05/16/2007

Accessibility Assistance
Contact the OSHA Directorate of Science, Technology and Medicine at 202-693-2300 for assistance accessing PDF materials.
Back to Top Back to Top www.osha.gov www.dol.gov

Contact Us | Freedom of Information Act | Customer Survey
Privacy and Security Statement | Disclaimers
Occupational Safety & Health Administration
200 Constitution Avenue, NW
Washington, DC 20210